03:30 PM EDT, 04/02/2026 (MT Newswires) -- Health care stocks declined late Thursday afternoon, with the NYSE Health Care Index down 0.5% and the State Street Health Care Select Sector SPDR ETF (XLV) shedding 0.9%.

The iShares Biotechnology ETF (IBB) fell 0.7%.

In corporate news, Alto Neuroscience ( ANRO ) shares fell past 8% in Thursday late afternoon trading, a day after the company said topline data from its phase 2 proof-of-concept trial assessing ALTO-101 was not statistically significant on primary electroencephalography or cognitive endpoints versus placebo.